LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
20 hedge funds and large institutions have $16.1M invested in LAVA Therapeutics in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
8.6% more ownership
Funds ownership: 30.61% → 39.2% (+8.6%)
5% more funds holding
Funds holding: 19 → 20 (+1)
Holders
20
Holding in Top 10
4
Calls
$226K
Puts
$63K
Top Buyers
| 1 | +$3.98M | |
| 2 | +$312K | |
| 3 | +$215K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$69K |
| 5 |
JC
JBF Capital
Aspen,
Colorado
|
+$37.3K |
Top Sellers
| 1 | -$689K | |
| 2 | -$135K | |
| 3 | -$61.9K | |
| 4 |
Two Sigma Investments
New York
|
-$45.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$18.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| – |
|